NCT01373242View on ClinicalTrials.gov

Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

April 16, 2018

Study Completion Date

April 16, 2018

Conditions
Peanut HypersensitivityFood HypersensitivityFood AllergyPeanut Allergy
Interventions
DRUG

Liquid peanut extract (Peanut SLIT)

Liquid peanut extract will be administered under the tongue

Trial Locations (1)

27599

University of North Carolina, Chapel Hill

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT01373242 - Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance | Biotech Hunter | Biotech Hunter